Skip to main content

Table 3 Viral load, RVR, ETR &SVR in Group 1 and Group 2 (Intention to Treat Analysis)

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

 Viral load detectable
Group 1(n = 18)Group 2 (n = 18)
NoYesNoYes
N (%)N (%)N (%)N (%)
4th Week (RVR)14 (77.7)1 (6.6)15 (83.3)2 (11.1)
8th Week15 (83.3)(0)17 (94.4)0 (0)
12th Week (ETR)15 (83.3)(0)17 (94.4)0 (0)
24th Week (SVR)15 (83.3)(0)14 (77.7)3 (16.6)